e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
McNicholas W. T., Bonsignore M. R., on behalf of the ...
Source:
Eur Respir J 2007; 29: 156-178
Journal Issue:
January
Disease area:
Pulmonary vascular diseases, Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
McNicholas W. T., Bonsignore M. R., on behalf of the .... Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-178
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
Is obstructive sleep apnoea a risk factor for cardiovascular disease?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005
Obstructive sleep apnea syndrome is an independent risk factor for progression of chronic kidney disease: A new link?
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation
Source: Eur Respir J 2009; 33: 1195-1205
Year: 2009
Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches
Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019
Year: 2020
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Physical activity: the key to cardiometabolic risk reduction in obstructive sleep apnoea
Source: Eur Respir J, 52 (4) 1801775; 10.1183/13993003.01775-2018
Year: 2018
Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases?
Source: Sleep and Breathing Conference 2017
Year: 2017
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015
Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006
Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005
Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
Source: Eur Respir Rev, 26 (144) 160110; 10.1183/16000617.0110-2016
Year: 2017
Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Obesity, sleep apnoea and COVID-19: relationship, risk and therapeutic implications
Source: Sleep and Breathing Conference 2021
Year: 2021
Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010
Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002
Obstructive sleep apnoea and COPD
Source: Eur Respir Mon 2013; 59: 135-143
Year: 2013
The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001
Smoking (active and former) among factors influencing severity of both pathologies in a population with obstructive sleep apnea (OSA) and chronic obstructive bronhopneumopathy (COPD)
Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Year: 2010
Treatment of obstructive and central sleep apnoea in heart failure: practical options
Source: Eur Respir Rev 2007; 16: 183-188
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept